Evidence map›Paper›PMID 36845015›Full record

ReviewDisease markers2023

The Roles of TRAF3 in Immune Responses.

Mengjiao Lin, Xiaoli Ji, Yan Lv, Dawei Cui, Jue Xie

Abstract readReview
In one paragraph

Review in Disease markers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. The miR-2110/Biochemistry and biophysics reports · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Genome-wide screen inbioRxiv : the preprint server for biology · 2025
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mengjiao LinDepartment of Blood Transfusion, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.ORCID https://orcid.org/0000-0002-1462-4098
Xiaoli JiDepartment of Ultrasound, Wenzhou City People's Hospital, Wenzhou 325100, China.ORCID https://orcid.org/0000-0002-2666-5946
Yan LvDepartment of Blood Transfusion, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.ORCID https://orcid.org/0000-0003-1075-436X
Dawei CuiDepartment of Blood Transfusion, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.ORCID https://orcid.org/0000-0003-3840-1486
Jue XieDepartment of Blood Transfusion, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.ORCID https://orcid.org/0000-0002-4270-671X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Seven tumor necrosis factor receptor- (TNFR-) associated factors (TRAFs) have been found in mammals, which are primarily involved in the signal translation of the TNFR superfamily, the Toll-like receptor (TLR) family, and the retinoic acid-inducible gene I- (RIG-I-) like receptor (RLR) family. TRAF3 is one of the most diverse members of the TRAF family. It can positively regulate type I interferon production while negatively regulating signaling pathways of classical nuclear factor-

Indexed as

NF-kappa BTNF Receptor-Associated Factor 3AnimalsHumansImmunity, InnateMammalsMitogen-Activated Protein KinasesSignal TransductionMitogen-Activated Protein KinasesNF-kappa BTNF Receptor-Associated Factor 3TRAF3 protein, human

Identifiers

PMID36845015
PMCPMC9949957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.